Abstract
Serum uric acid is representative for xanthine-oxidase, the key enzyme involved in the production of uric acid, which is up-regulated in the failing heart, and may play an important role in the pathophysiologic process that leads to heart failure. In our study, we investigated the relation between stroke volume, cardiac output and serum uric acid in a large sample of overall healthy pharmacologically untreated subjects. The Brisighella Heart Study included 2,939 men and women between the ages of 14–84 without prior coronary heart disease or cerebrovascular disease who were not taking antihypertensive therapy at baseline. For this study, we selected 734 adult subjects enrolled in the last Brisighella population survey not taking antihypertensive, antidiabetic, lipid-lowering and uric acid-lowering drugs, and who were also not affected by chronic heart failure or by gout. The main predictors of cardiac functionality parameters were mean arterial pressure (MAP), HR, SUA and age (all p < 0.001), while gender, BMI, LDL-cholesterol, HDL-cholesterol, triglycerides, fasting plasma glucose, creatinine, estimated glomerular filtration rate, physical activity and smoking habit were not significantly associated (all p > 0.05). In particular, there is a strong relation between estimated cardiac output and serum uric acid (B = −0.219, p < 0.001) and between stroke volume and serum uric acid (B = −3.684, p < 0.001). These observations might have an impact on future considerations about serum uric acid as an early inexpensive marker of heart function decline in the general population.
Similar content being viewed by others
References
Pasalic D, Marinkovic N, Feher-Turkovic L (2012) Uric acid as one of the important factors in multifactorial disorders–facts and controversies. Biochem Med 22:63–75
Soltani Z, Rasheed K, Kapusta DR, Reisin E (2013) Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 15(3):175–181. doi:10.1007/s11906-013-0344-5
Kivity S, Kopel E, Maor E, Abu-Bachar F, Segev S, Sidi Y, Olchovsky D (2013) Association of serum uric acid and cardiovascular disease in healthy adults. Am J Cardiol 111:1146–1151. doi:10.1016/j.amjcard.2012.12.034
Duan X, Ling F (2008) Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 70:578–581
Shankar A, Klein R, Klein BEK, Nieto FJ (2006) The association between serum UA level and long-term incidence of hypertension: population based cohort study. J Hum Hypertens 20:937–945
Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum UA and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215
Harzand A, Tamariz L, Hare JM (2012) Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition. Congest Heart Fail 18:179–182. doi:10.1111/j.1751-7133.2011.00262.x
Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J (2011) UA as a predictor of all-cause mortality in HF: a meta-analysis. Congest Heart Fail 17:25–30. doi:10.1111/j.1751-7133.2011.00200.x
Cicero AFG, Dormi A, D’Addato S, Borghi C (2011) From risk factor assessment to cardiovascular disease risk and mortality modification. The first 40 years of the Brisighella Heart Study. Clin Lipidol 6:269–276
Cicero AFG, D’Addato S, Santi F, Ferroni A, Borghi C, on behalf of the Brisighella Heart Study group (2012) Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med 13:559–564
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention; National heart, lung, and blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM (2009) Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res 32:1079–1085. doi:10.1038/hr.2009
Pucci G, Cheriyan J, Hubsch A, Hickson SS, Gajendragadkar PR, Watson T, O’Sullivan M, Woodcock-Smith J, Schillaci G, Wilkinson IB, McEniery CM (2013) Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens 31:77–85. doi:10.1097/HJH.0b013e32835a8eb1
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018
Floras JS (2009) Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54:375–385. doi:10.1016/j.jacc.2009.03.061
Zimmet JM, Hare JM (2006) Nitroso-redox interactions in the cardiovascular system. Circulation 114:1531–1544
Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998
Jeemon P, Prabhakaran D (2013) Does uric acid qualify as an independent risk factor for cardiovascular mortality? Clin Sci (Lond) 124:255–257. doi:10.1042/CS20120524
Amin A, Vakilian F, Maleki M (2011) Serum uric acid levels correlate with filling pressures in systolic heart failure. Congest Heart Fail 17:80–84. doi:10.1111/j.1751-7133.2010.00205.x
Krishnan E, Hariri A, Dabbous O, Pandya BJ (2012) Hyperuricemia and the echocardiographic measures of myocardial dysfunction. Congest Heart Fail 18:138–143. doi:10.1111/j.1751-7133.2011.00259.x
Krishnan E (2009) Hyperuricemia and incident heart failure. Circ Heart Fail 2:556–562. doi:10.1161/CIRCHEARTFAILURE.108.797662
Baldasseroni S, Urso R, Maggioni AP, Orso F, Fabbri G, Marchionni N, Tavazzi L, IN-CHF Investigators (2012) Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 22:442–448. doi:10.1016/j.numecd.2010.08.007
Tang ZH, Fang Z, Zeng F, Li Z, Zhou L (2013) Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure. J Endocrinol Invest [Epub ahead of print]
Mulè G, Nardi E, Costanzo M, Mogavero M, Guarino L, Viola T, Vario MG, Cacciatore V, Andronico G, Cerasola G, Cottone S (2013) Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men. Nutr Metab Cardiovasc Dis 23:715–722. doi:10.1016/j.numecd.2012.01.007
Savarese G, Ferri C, Trimarco B, Rosano G, Dellegrottaglie S, Losco T, Casaretti L, D’Amore C, Gambardella F, Prastaro M, Rengo G, Leosco D, Perrone-Filardi P (2013) Changes in serum uric acid levels and cardiovascular events: a meta-analysis. Nutr Metab Cardiovasc Dis 23:707–714. doi:10.1016/j.numecd.2013.03.001
Springer J, Tschirner A, Hartman K, von Haehling S, Anker SD, Doehner W (2013) The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy. Int J Cardiol. doi:10.1016/j.ijcard.2013.05.063
Baldus S, Müllerleile K, Chumley P, Steven D, Rudolph V, Lund GK, Staude HJ, Stork A, Köster R, Kähler J, Weiss C, Münzel T, Meinertz T, Freeman BA, Heitzer T (2006) Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 41:1282–1288
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
For the Brisighella Heart Study group.
Rights and permissions
About this article
Cite this article
Cicero, A.F.G., Rosticci, M., Parini, A. et al. Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study. Intern Emerg Med 9, 655–660 (2014). https://doi.org/10.1007/s11739-013-1016-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-013-1016-9